XPAT® proteins, conditionally activated T-cell engagers engineered to mitigate on-target, off-tumor toxicity for immunotherapy of solid tumors
Fiore Cattaruzza(Sanofi (United States)), Volker Schellenberger(VIR Biotechnology (United States))
Cited by 1
Related Papers
The TGR5 receptor mediates bile acid–induced itch and analgesia
|Journal of Clinical Investigation|2013|374